NCT06389552
Long-term Observational Study to Evaluate the DFS and OS of Adjuvant FOLFIRINOX Regimen in Pancreatic Cancer Patients
StatusActive, Not Recruiting
PhaseNot specified
SponsorHK inno.N Corporation
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 8 words
- Enrollment closed, study ongoing
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Disease-free survival
Timeframe: Day 1 to Week 88
Secondary (1)
Overall survival
Sites
1 site in 1 country
- Seoul ST. Mary's HospitalSeoul, South Korea